Several studies reported that HDAC10 was related to the progression and biological features in cervical cancer: HDAC10 inhibits the metastasis of cervical carcinoma through downregulating the expression of MMP2 and MMP9 [8]; HDAC10 promotes the cervical cancer progression in vitro while the mechanism is still unclear and remains to be further explored [9]. Here, MMP9 is linked to cervical carcinoma.